GlobeNewswire by notified

Coface records a very good start to the year with a net income of €61.2m


Coface records a very good start to the year with a net income of €61.2m

Paris, 25 May 2023 – 17.35

  • Coface applied IFRS 17 and IFRS 9 accounting standards starting on 1January2023. All comparisons are made using the 2022 pro forma IFRS 17 figures presented on 27 April 2023
  • Turnover: €475m, up 11.4% at constant perimeter and FX
    • Trade Credit insurance rose 10.9% at constant FX, driven by increased client activity and growth in fee and commission income (+12.8%)
    • Client retention stood at record highs (95.7%); the price effect was still negative (-1.5%) but less so than Q4-22
    • Information services rose 15.0% at constant FX, while factoring climbed 13.1%
  • Net loss ratio at 40.6%, up by 0.3 ppt; net combined ratio at 66.3%, improved by 1.7 ppt (+10.3 ppts compared to Q1-22, excluding the impact of government schemes)
    • Gross loss ratio at 40.7%, up 9.2 ppts in a risk environment that is still slowly normalising
    • Net cost ratio down by 2.1 ppts to 25.7% as a result of positive operating leverage, an improved product mix and high reinsurance commissions
  • Net income (group share) at €61.2m, up 17.0% compared to Q1-22
  • Annualised RoATE1at 13.6%
  • Payment of the 2022 dividend of €1.522approved at the General Meeting of 16 May 2023

Unless otherwise indicated, change comparisons refer to the pro forma IFRS 17 results as at 31 March 2022

Xavier Durand, Coface’s Chief Executive Officer, commented:
“Coface maintained its growth trend with an 11.4% increase in turnover and a record customer retention rate. Other activities, including service revenues (information sales, debt collection and fee and commission income) continued to grow double digits, once again proving the solidity of Coface's business model.
While helping moderate inflation, ongoing monetary tightening by the main central banks also revealed weaknesses in a financial system that had become accustomed to very low rates. Fears arising from the bankruptcies of US regional banks will likely lead to a general reduction in the corporate credit supply.
The first quarter of 2023 is also the first to which the IFRS 17 and IFRS 9 accounting standards were applied. These standards did not cause any major changes to the assessment of Coface's financial performance, which remains strong. Under this new accounting framework, Coface posted a 17% increase in net income to €61.2m and a net combined ratio of 66.3% for an annualised return on tangible equity of 13.6%, above mid-cycle targets.
Lastly, following the general meeting of 16 May, a dividend of €1.52 per share (which corresponds to 80% of our 2022 earnings) was paid on 24 May 2023.”

Key figures at 31 March 2023

The Board of Directors of COFACE SA examined the summary consolidated financial statements for the first three months (non-audited) during its meeting on 25 may 2023. The Audit Committee had previously reviewed them at its meeting on 23 May 2023.

Income statements items in €mQ1-22Q1-23Variation% ex. FX*
Gross earned premiums359.2395.3+10.1%+10.9%
Other revenues68.879.8+16.0%+13.9%
Investment income, net of management expenses11.3-2.6(123.2)%(122.0)%
Insurance Finance Expenses(11.5)(2.4)(79.5)%(70.3)%
Other operating income / expenses(1.2)(0.3)(70.1)%(78.6)%
OPERATING INCOME80.890.0+11.4%+7.0%
NET INCOME52.361.2+17.0%+7.8%
Key ratiosQ1-22Q1-23Variation
Loss ratio net of reinsurance40.3%40.6%0.3ppt
Cost ratio net of reinsurance27.8%25.7%(2.1)ppts
Balance sheet items in €m2022Q1-23Variation
Total Equity (group share)2,018.62,100.4+4.1%

* Also excludes scope impact

1.   Turnover

Coface recorded a consolidated turnover of €475.1m, up 11.4% at constant perimeter and FX compared to Q1- 22. As reported (at current FX and perimeter), turnover rose +11.0%.

Turnover from the insurance business (including surety bonds and single risk) increased +10.9% at constant perimeter and FX. Growth benefited from a sharp increase in customer activity as well as a record retention level of 95.7%, up +0.9% compared to Q1-22. New business totalled €32m, down €3m compared to Q1-22 in an increasingly competitive market and approaching pre-COVID levels.

The growth in Coface’s client activity had a positive impact of +2.0% during Q1-23. This increase continues to reflect the scale of the recent economic recovery and inflation, but the pace of growth is now slowing (-2.4 ppts compared to Q1-22). The price effect remained negative at -1.5% in Q1-23 but improved compared to Q1-22 (- 2.7%). This decrease is largely explained by a very low past claims experience and moderated by the continued normalisation of the risk environment.

Turnover from non-insurance activities was up +15.3% compared to Q1-22. All the business lines are experiencing positive trends but at different scales. Turnover from factoring rose +13.1%, mainly due to the increase in volumes refinanced in Germany. Information services turnover rose +15.0%, maintaining its growth trend. Fee and commission income (debt collection commissions) increased +44.1% due to the increase in claims to be collected. Commissions were up +12.8%.

Total revenue - in €m
(by country of invoicing)
Q1-22Q1-23Variation% ex. FX3
Northern Europe94.7102.2+7.9%+7.2%
Western Europe79.896.6+21.1%+21.8%
Central & Eastern Europe46.945.0(4.1)%(4.6)%
Mediterranean & Africa115.9133.2+14.9%+17.2%
North America36.241.9+15.8%+11.9%
Latin America22.926.4+15.5%+20.3%
Asia Pacific31.529.8(5.5)%(6.6)%
Total Group428.0 475.111.0%+11.4%

In Northern Europe, turnover increased +7.2% at constant FX and +7.9% at current FX. Credit insurance benefited from client activity, despite the decrease in metal prices, and from a high retention rate. Turnover from factoring and services increased +15.5% and +44.6% respectively.

In Western Europe, turnover was up +21.8% at constant FX (+21.1% at current FX) due to a high retention rate and client activity.

In Central and Eastern Europe, turnover decreased by -4.6% and -4.1% at current FX due to reduced exposure to Russia and the decline in metal prices. Excluding Russia, growth would be 1%. Factoring turnover increased by +2.0%.

In the Mediterranean and Africa region, which is driven by Italy and Spain, turnover rose +17.2% and +14.9% at current FX due to a high retention rate and client activity. Commissions climbed by +20.8%.

In North America, turnover increased +11.9% at constant FX and +15.8% as reported, driven mainly by improved retention.

In Latin America, turnover was up +20.3% at constant FX and +15.5% at current FX, driven by high retention and the increase in client activity

In Asia-Pacific, turnover fell -6.6% at constant FX and -5.5% at current FX. The slip in turnover was mainly a result of the decline in activity due to exposure to the information technology sector.

2.   Result

  • Combined ratio

The combined ratio net of reinsurance stood at 66.2% for Q1-23 (an improvement of 1.8 ppt year on year and 7.2 ppts compared to the previous quarter). This ratio was up 10.3 ppts compared to Q1-22, excluding the effect of the government schemes.

(i)  Loss ratio

The gross loss ratio stood at 40.7%, up 9.2 ppts year on year. This reflects an increased claims frequency since H1-21, with the number of claims close to pre-COVID levels, and the return of relatively large claims, which nevertheless remain below average. Reserve releases remain high.
The Group’s reserving policy remains unchanged. The amount of provisions relating to the underwriting year, although discounted, remains in line with the historical average. The rigorous management of past claims enabled the Group to record 35.6 ppts of recoveries on previous years. Releases from previous years no longer benefited as much from COVID-related reserves.
The net loss ratio rose to 40.6%, an increase of 0.3 ppt compared to T1-22 (and up 10.7 ppts compared to Q1-22, excluding the impact of government schemes).

(ii)  Cost ratio

Coface follows a strict cost management policy. In Q1-23, costs rose by +10.9% at constant perimeter and FX, and +10.7% at current FX. Credit insurance costs were up 7.9%, which was less than the increase in turnover, demonstrating good operating leverage. The cost ratio before reinsurance stood at 29.4%, down 1.2 ppt year on year due to an improvement in the product mix (commissions).

The cost ratio net of reinsurance was 25.7% in Q1-23, an improvement of 2.1 ppts year on year.

  • Financial result

Net financial income for the first quarter was -€2.6m. This amount includes market value adjustments particularly on real estate funds for -€12m, positive hedging results and a currency effect of -€6.3m, which is mainly due to the application of IAS 29 (hyperinflation) in Argentina and Turkey.

The portfolio’s current yield (i.e. excluding capital gains, impairment and currency effects) was €14.6m, i.e. a two-fold increase year on year. The accounting yield4, excluding capital gains and fair value effect, was 0.5% in Q1-23. The return on new investments remained above 2%.

  • Operating income and net income

Operating income for Q1-23 was €90.0m, up 11.4% year on year, mainly due to increased turnover and a loss experience that remained low.

The effective tax rate was 25%, compared to 31% for Q1-22.

In total, net income (group share) stood at €61.2m, up 17.0% compared to Q1-22.

3.   Shareholders’ equity

At 31 March 2023, Group shareholders’ equity stood at €2,100.4m, up €81.8m, i.e. +4.1% (compared to €2,018.6m at 31 December 2022).

This change is mainly due to positive net income of €61.2m, and positive adjustments to the fair value of investments (€24.2m).

The annualised return on average tangible equity (RoATE) was 13.6% in Q1-23.

4.   Outlook

As expected, inflation continued to decline due to the fall in commodity prices (particularly energy prices) and the proactive measures taken by central banks. The many monetary tightening measures in the main economic hubs have started making their impact. However, the excellent state of the labour market limited the negative consequences of this new policy. The transmission of monetary policies to the economy is not immediate and its full effect has yet to be observed.

One of the most visible consequences of this tightening was the bankruptcy of a number of US banks due to a lack of supervision and regulation. At this stage, the takeover of these banks by stronger players has limited contagion. However, the other regional banks are encouraged to reduce their commitments, which could lead to a contraction in the credit supply available to households and businesses.

Against this backdrop, the number of corporate bankruptcies continued to rise, albeit at a more moderate pace than expected.

Lower inflation has led to slowed growth in trade credit insurance turnover. On the other hand, other activities and in particular service revenues (information, debt collection and fee and commission income) continued to grow in double digits, improving Coface's product mix.

Conference call for financial analysts

Coface’s results for 3M-2023 will be discussed with financial analysts during the conference call on Thursday 25 May at 18.00 (Paris time). Dial one of the following numbers:

The presentation will be available (in English only) at the following address:


Quarterly results

Income statements items in €m
quarterly figures
ex. FX*
Gross earned premiums359.2374.0403.5379.0395.3+10.1%+10.9%
Other revenues68.871.670.173.079.8+16.0%+13.9%
Investment income,
net of management expenses
Insurance Finance Expenses(11.5)(10.4)(10.5)14.9(2.4)(79.5)%(70.3)%
CURRENT OPERATING INCOME82.0110.687.986.290.4+10.2%+5.8%
Other operating income / expenses(1.2)(3.2)(0.7)(4.1)(0.3)(70.1)%(78.6)%
OPERATING INCOME80.8107.487.382.190.0+11.4%+7.0%
NET INCOME52.382.551.054.661.2+17.0%+7.8%
Income tax rate31.0%19.3%32.8%25.5%25.5%-5.5 ppts.

Cumulated results

Income statements items in €m
cumulated figures
ex. FX*
Gross earned premiums359.2733.21,136.61,515.7395.3+10.1%+10.9%
Other revenues68.8140.4210.4283.479.8+16.0%+13.9%
Investment income,
net of management expenses
Insurance Finance Expenses(11.5)(21.9)(32.4)(17.6)(2.4)(79.5)%(70.3)%
CURRENT OPERATING INCOME82.0192.6280.5366.890.4+10.2%+5.8%
Other operating income / expenses(1.2)(4.3)(5.0)(9.1)(0.3)(70.1)%(78.6)%
OPERATING INCOME80.8188.3275.5357.790.0+11.4%+7.0%
NET INCOME52.3134.8185.8240.461.2+17.0%+7.8%
Income tax rate31.0%24.3%26.8%26.5%25.5%-5.5 ppts.

* Also excludes scope impact


Thomas JACQUET: +33 1 49 02 12 58 –
Benoît CHASTEL: +33 1 49 02 22 28 –

Saphia GAOUAOUI: +33 1 49 02 14 91 –
Corentin HENRY: +33 1 49 02 23 94 –

(subject to change)
H1-2023 results: 10 August 2023 (after market close)
9M-2023 results: 14 November 2023 (after market close)

This press release, as well as COFACE SA’s integral regulatory information, can be found on the Group’s website:

For regulated information on Alternative Performance Measures (APM), please refer to our Interim Financial Report for H1-2022 and our 2022 Universal Registration Document (see part 3.7 “Key financial performance indicators”).

Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website

With over 75 years of experience and the most extensive international network, Coface is a leader in trade credit insurance & risk management, and a recognized provider of Factoring, Debt Collection, Single Risk insurance, Bonding, and Information Services. Coface’s experts work to the beat of the global economy, helping ~50,000 clients in 100 countries build successful, growing, and dynamic businesses. With Coface’s insight and advice, these companies can make informed decisions. The Group' solutions strengthen their ability to sell by providing them with reliable information on their commercial partners and protecting them against non-payment risks, both domestically and for export. In 2022, Coface employed ~4,720 people and registered a turnover of €1.81 billion.

COFACE SA is quoted in Compartment A of Euronext Paris
Code ISIN: FR0010667147 / Mnémonique : COFA

DISCLAIMER - Certain declarations featured in this press release may contain forecasts that notably relate to future events, trends, projects or targets. By nature, these forecasts include identified or unidentified risks and uncertainties, and may be affected by many factors likely to give rise to a significant discrepancy between the real results and those stated in these declarations. Please refer to chapter 5 “Main risk factors and their management within the Group” of the Coface Group's 2022 Universal Registration Document filed with AMF on 6 April 2023 under the number D.23-0244 in order to obtain a description of certain major factors, risks and uncertainties likely to influence the Coface Group's businesses. The Coface Group disclaims any intention or obligation to publish an update of these forecasts, or provide new information on future events or any other circumstance.

1 Return on average tangible equity
2The proposed payment was approved at the General Shareholders’ Meeting on 16 May 2023. The ex-dividend date and payment of the dividend took place on 22 and 24 May 2023 respectively.
3Also excludes scope impact
4Book yield calculated on the average of the investment portfolio excluding non-consolidated subsidiaries.


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock5.6.2023 23:30:00 CEST | Press release

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing of its private placement of redeemable convertible preferred stock and warrants resulting in initial gross proceeds of $28.0 million to Telesis Bio. The warrants issued in the private placement will provide Telesis Bio with approximately $46.2 million in additional gross proceeds if they are cash exercised. The financing was led by Novalis LifeSciences LLC with participation from Northpond Ventures, BroadOak Capital Partners and M-185 Corporation, an affiliate of the Company’s Chief Executive Officer and Founder, Todd R. Nelson, PhD. The Company also announced the appointment of Paul Meister, a partner at Novalis LifeSciences LLC, to the Company’s board of directors immediately following the closing. Please refer to the Company’s Form 8-K to be filed with the Securities and Exchang

Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress5.6.2023 22:01:00 CEST | Press release

All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or without Richter’s Transformation (RT), responded to treatment (Objective Response Rate of 100%)1 GLPG5201 showed no cytokine release syndrome (CRS) higher than grade 2, or immune effector cell-associated neurotoxicity syndrome (ICANS)2 A functionally closed, automated manufacturing platform for cell therapies at the point-of-care will be shown at the Galapagos booth A.103at the EHA 2023 congress Mechelen, Belgium; 5 June 2023,22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will feature theCAR-T point-of-care manufacturing platform and willpresent previously disclosed initial Phase 1/2 data with CD19 CAR-T candidate, GLPG5201, at the European Hematology Association (EHA) 2023 congress, taking place from 8 June to 11June 2023 in Frankfurt, Germany. “Patients who develop rrCLL and become resistant to new agents have a very poor prognosis and a significant high

Hoylu AB: Publicerar årsredovisning för 20225.6.2023 21:15:00 CEST | Pressemelding

Hoylu AB (publ) meddelar idag att årsredovisningen för räkenskapsåret 2022 bifogas detta pressmeddelande och finns tillgänglig på bolagets hemsida: ( För mer information kontakta: Truls Baklid, CEO, +47 924 38 900 Email: Karl Wiersholm, CFO, +1 425 829 2316 Email: Om Hoylu Hoylus uppdrag är att ge distribuerade team möjlighet att samarbeta enkelt och sömlöst samtidigt som de alltid håller sig synkroniserade. Hoylus Adaptive Workspaces™ hjälper företag såväl stora som små att driva projekt, program och initiativ över olika tidszoner och kontinenter med samma engagemang och tydlighet som om alla arbetade i samma rum. För mer information: Kortnamn: Hoylu Marknadsplats: Nasdaq First North Growth Stockholm Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550; Publicering Informationen lämnades, genom ovanstående kontaktpersons försorg för offentliggörande den 5 ju

Hoylu AB: Publishes its Annual Report for 20225.6.2023 21:15:00 CEST | Press release

Hoylu AB (publ) announced today that the Annual Report for 2022 is attached to this press release and is available on Hoylu's web site: ( For more information contact: Truls Baklid, CEO, +47 924 38 900 Email: Karl Wiersholm, CFO, +1 425 829 2316 Email: About Hoylu Hoylu’s visual collaboration technology empowers distributed teams to translate ideas into actions. Large enterprises as well as small and medium companies rely on Hoylu to run projects, programs, and initiatives across time zones and continents as seamlessly as when working in the same room. For more information: Try Hoylu for free: Ticker symbol: Hoylu Marketplace: Nasdaq First North Growth Market Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550, Publication The information was submitted for publication, through the agency of the contact person set out above, at 21:15 CE

Nokia Corporation: Repurchase of own shares on 05.06.20235.6.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 5 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 05.06.2023 Espoo, Finland – On 5 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL308,5933.85CEUX48,4053.86AQEU4,7293.86TQEX3,3733.87Total365,1003.86 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and en